Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Public ClinicalTrials.gov record NCT01486264. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will compare Xeomin®, a botulinum toxin medication, in shorter treatment intervals (Short Flex dosing) to the standard interval dosing (Long Flex dosing) to determine if the response to treatment is comparable in both how it works and any side effects. Xeomin® is approved by the United States Food and Drug Administration (FDA) for the treatment of cervical dystonia (CD). The use of Xeomin® is investigational in regards to shorter treatment intervals. An investigational use is one that is not approved by the FDA.
Study identification
- NCT ID
- NCT01486264
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 283 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 81 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 20, 2012 (Actual)
- Primary completion
- Mar 29, 2016 (Actual)
- Completion
- Mar 29, 2016 (Actual)
- Last update posted
- Oct 27, 2022
2012 – 2016
United States locations
- U.S. sites
- 43
- U.S. states
- 22
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Merz Investigative Site #001234 | Birmingham | Alabama | 35294-0017 | — |
| Merz Investigative Site 001017 | Fountain Valley | California | 92708 | — |
| Merz Investigative Site #001225 | Loma Linda | California | 92354-3450 | — |
| Merz Investigative Site #001219 | Los Angeles | California | 90033 | — |
| Merz Investigative Site # 001276 | Manchester | Connecticut | 06040 | — |
| Merz Investigative Site #001231 | Washington D.C. | District of Columbia | 20007 | — |
| Merz Investigative Site #001076 | Boca Raton | Florida | 33486 | — |
| Merz Investigative Site #001019 | Gainesville | Florida | 32610 | — |
| Merz Investigative Site #001046 | Jacksonville | Florida | 32209 | — |
| Merz Investigative Site #001075 | Melbourne | Florida | 32901 | — |
| Merz Investigative Site #001217 | Port Charlotte | Florida | 33980 | — |
| Merz Investigative Site #1253 | Tampa | Florida | 33613 | — |
| Merz Investigative Site #001055 | Atlanta | Georgia | 30329 | — |
| Merz Investigative Site# 01255 | Chicago | Illinois | 60611 | — |
| Merz Investigative Site #001215 | Chicago | Illinois | 60612 | — |
| Merz Investigative Site # 01069 | Des Moines | Iowa | 50309 | — |
| Merz Investigative Site #001110 | Overland Park | Kansas | 66211 | — |
| Merz Investigative Site # 001071 | Elkridge | Maryland | 21075 | — |
| Merz Investigative Site # 001018 | Detroit | Michigan | 48201-2153 | — |
| Merz Investigative Site #001030 | Farmington Hills | Michigan | 48334 | — |
| Merz Investigative Site # 0001275 | Eagan | Minnesota | 55121 | — |
| Merz Investigative Site #1250 | St Louis | Missouri | 63104 | — |
| Merz Investigative Site #001210 | St Louis | Missouri | 63110 | — |
| Merz Investigative Site #001221 | Albany | New York | 12208 | — |
| Merz Investigative Site #001233 | New York | New York | 10003 | — |
| Merz Investigative Site #1256 | New York | New York | 10029-6574 | — |
| Merz Investigative Site# 01252 | Charlotte | North Carolina | 28207 | — |
| Merz Investigative Site #001005 | Durham | North Carolina | 27705 | — |
| Merz Investigative Site# 01260 | Raleigh | North Carolina | 27607 | — |
| Merz Investigative Site #001009 | Winston-Salem | North Carolina | 27157 | — |
| Merz Investigative Site #1265 | Cincinnati | Ohio | 45219 | — |
| Merz Investigative Site #001220 | Tulsa | Oklahoma | 74136 | — |
| Merz Investigative Site #1033 | Portland | Oregon | 97239 | — |
| Merz Investigative Site #1251 | Portland | Oregon | 97239 | — |
| Merz Investigative Site # 0001271 | Hershey | Pennsylvania | 17033 | — |
| Merz Investigative Site #1249 | Philadelphia | Pennsylvania | 19107 | — |
| Merz Investigative Site #001206 | Nashville | Tennessee | 37232-2551 | — |
| Merz Investigative Site #1074 | Dallas | Texas | 75214 | — |
| Merz Investigative Site #001223 | Dallas | Texas | 75231 | — |
| Merz Investigative Site # 001216 | Houston | Texas | 77030 | — |
| Merz Investigative Site# 001266 | Houston | Texas | 77030 | — |
| Merz Investigative Site #001224 | Kirkland | Washington | 98034 | — |
| Merz Investigative Site #1270 | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01486264, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 27, 2022 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01486264 live on ClinicalTrials.gov.